You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Patent: 10,184,121


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,184,121
Title:Methods for removing viral contaminants from pancreatic extracts
Abstract: Methods for screening pancrelipase for RNA virus contamination comprise removing free viral RNA from the pancrelipase, denaturing any viruses in the pancrelipase to release encapsidated RNA into the pancrelipase milieu, and detecting this released RNA. Removal of free viral RNA may comprise treating pancrelipase with RNase and DNase or precipitating the protein fraction of pancrelipase with a salt that precipitates the protein fraction while leaving nucleic acids such as RNA in solution. Pancrelipase substantially devoid of free nucleic acid is also provided.
Inventor(s): Ortenzi; Giovanni (Monza, IT), Ghidorsi; Luigi (Milan, IT)
Assignee: ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED (Dublin, IE)
Application Number:14/744,447
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide Using USPTO Resources

Introduction

When analyzing the scope and claims of a U.S. patent, such as U.S. Patent 10,184,121, it is crucial to understand the various tools and resources available through the United States Patent and Trademark Office (USPTO) and other relevant institutions. This article will guide you through the process, highlighting key resources and methodologies.

Understanding Patent Types

Before diving into the specifics of a patent, it's essential to know the types of patents that exist. There are three main types: utility patents, design patents, and plant patents. Each type has its own criteria and scope of protection[4].

Accessing Patent Information

To analyze a patent, you need to access its documentation. The USPTO provides several tools for this purpose:

Patent Public Search

The Patent Public Search tool is a modern web-based application that replaces older tools like PubEast and PubWest. It offers enhanced access to prior art and two user-selectable interfaces, making the patent searching process more efficient[1].

Global Dossier

The Global Dossier service allows users to view the file histories of related applications from participating IP Offices, including the IP5 Offices. This is particularly useful for understanding the global patent family and related citations[1].

Public Search Facility

The USPTO Public Search Facility in Alexandria, VA, provides access to patent and trademark information in various formats, including online, microfilm, and print. Trained staff are available to assist users[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs maintain search resources and may offer training in patent search techniques, making them valuable for detailed analyses[1].

Analyzing Patent Claims

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset contains detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. This dataset can help in understanding claim structures and dependencies[3].

Claim-Level Statistics

The dataset includes claim-level statistics and document-level statistics, such as measures of patent scope. These statistics can provide insights into the breadth and depth of the patent claims[3].

Examining the Patent Landscape

Common Citation Document (CCD)

The CCD application consolidates prior art cited by all participating offices for the family members of a patent application. This helps in visualizing the search results for the same invention produced by several offices on a single page[1].

International Patent Databases

To see if an idea has been patented abroad, you can use databases from other International Intellectual Property offices such as the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO)[1].

Case Study: U.S. Patent 10,184,121

Retrieving the Patent Document

To analyze U.S. Patent 10,184,121, start by retrieving the patent document using the Patent Public Search tool or other search facilities provided by the USPTO.

Understanding the Claims

Carefully read and analyze the claims section of the patent. This section outlines what the inventor claims as their invention. Use the Patent Claims Research Dataset to understand the structure and dependencies of these claims.

Evaluating Prior Art

Use the Global Dossier and CCD to evaluate prior art cited by various offices. This helps in understanding how the patent fits into the broader patent landscape.

Assessing Patent Scope

Refer to the Patent Claims Research Dataset for measures of patent scope. This can help in determining the breadth and depth of the protection granted by the patent[3].

Legal and Policy Considerations

Subject Matter Eligibility

Ensure that the patent claims comply with subject matter eligibility criteria. The USPTO provides guidance updates on this topic, which can be crucial in evaluating the validity of the patent claims[5].

Potential for Small Claims Patent Court

Consider the feasibility of a small claims patent court, which could impact how disputes related to this patent are handled. The Administrative Conference of the United States (ACUS) has conducted studies on this topic, providing insights into the legal and policy considerations[2].

Practical Steps for Analysis

Step 1: Search for the Patent

Use the Patent Public Search tool to find U.S. Patent 10,184,121.

Step 2: Review the Claims

Analyze the claims section to understand what is being claimed.

Step 3: Evaluate Prior Art

Use the Global Dossier and CCD to assess prior art.

Step 4: Assess Patent Scope

Refer to the Patent Claims Research Dataset for measures of patent scope.

Step 5: Consider Legal and Policy Aspects

Review guidance on subject matter eligibility and consider the implications of a small claims patent court.

Example: Analyzing U.S. Patent 10,184,121

<blockquote>
To illustrate, let's consider a hypothetical analysis of U.S. Patent 10,184,121. First, retrieve the patent document using the Patent Public Search tool. Next, carefully analyze the claims to understand the scope of the invention. Use the Global Dossier to see if there are related applications in other countries and evaluate prior art using the CCD. Finally, refer to the Patent Claims Research Dataset to assess the breadth and depth of the patent claims.
</blockquote>

Key Takeaways

  • Access to Resources: Utilize the USPTO's Patent Public Search, Global Dossier, and other tools to access and analyze patent documents.
  • Claim Analysis: Use the Patent Claims Research Dataset to understand claim structures and dependencies.
  • Prior Art Evaluation: Employ the Global Dossier and CCD to assess prior art.
  • Patent Scope: Refer to the Patent Claims Research Dataset for measures of patent scope.
  • Legal Considerations: Ensure compliance with subject matter eligibility criteria and consider the implications of a small claims patent court.

FAQs

Q1: How do I search for a specific U.S. patent?

You can search for a specific U.S. patent using the Patent Public Search tool provided by the USPTO.

Q2: What is the Global Dossier service?

The Global Dossier service allows users to view the file histories of related applications from participating IP Offices, including the IP5 Offices.

Q3: How can I evaluate prior art for a patent?

Use the Common Citation Document (CCD) application to consolidate prior art cited by all participating offices for the family members of a patent application.

Q4: What is the Patent Claims Research Dataset?

The Patent Claims Research Dataset contains detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014.

Q5: How do I assess the scope of a patent?

Refer to the Patent Claims Research Dataset for measures of patent scope, which include claim-level statistics and document-level statistics.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. NYS Library - United States Patents: Collections: https://www.nysl.nysed.gov/reference/patents/
  5. Federal Register - Guidance Update on Patent Subject Matter Eligibility: https://unblock.federalregister.gov/2024 Guidance Update on Patent Subject Matter Eligibility, Including ...

More… ↓

⤷  Subscribe

Details for Patent 10,184,121

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. COTAZYM pancrelipase Capsule, Delayed Release 020580 December 09, 1996 ⤷  Subscribe 2034-06-19
Abbvie Inc. CREON pancrelipase Capsule, Delayed Release 020725 April 30, 2009 ⤷  Subscribe 2034-06-19
Abbvie Inc. CREON pancrelipase Capsule, Delayed Release 020725 June 10, 2011 ⤷  Subscribe 2034-06-19
Abbvie Inc. CREON pancrelipase Capsule, Delayed Release 020725 March 14, 2013 ⤷  Subscribe 2034-06-19
Digestive Care, Inc. PERTZYE pancrelipase Capsule, Delayed Release 022175 May 17, 2012 ⤷  Subscribe 2034-06-19
Digestive Care, Inc. PERTZYE pancrelipase Capsule, Delayed Release 022175 October 06, 2016 ⤷  Subscribe 2034-06-19
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.